Flosequinan is a fluorinated quinolone derivative without antibacterial activity, used as a direct venodilator and arteriodilator to reduce both preload and afterload. It inhibits phosphoinositide metabolism, promoting the mobilization of intracellular stored calcium, and exhibits mild positive inotropic effects. It is indicated for the treatment of congestive heart failure in patients who are unresponsive to diuretics, intolerant to ACE inhibitors, or inadequately managed with ACE inhibitor-based regimens.